neurological deficits – Page 2 – Communicable Diseases Research

Neurological Disorders Associated With COVID-19 Hospital Admissions: Experience of a Single Tertiary Healthcare Center

Neurology

Published on 2021-02-192022-11-01
Journal: Frontiers in Neurology [Category] COVID-19,

[키워드] addition Admission age Anosmia Autoimmune categories center Cohort Confusion COVID-19 COVID-19 infection COVID-19 patient Critical care database delirium determine diagnosed disorder Effect Encephalitis Encephalopathy etiology event experience Features FIVE Follow-up functional Hemorrhagic hospitalized COVID-19 patients hospitalized patient incidence Infection Inflammatory Inpatient Laboratory lack longitudinal males Multiple nervous system neurological deficits Neurological disorder Neurological disorders neurological phenotype Neurological symptom Neurological symptoms NEUROLOGY non-specific outcome Patient Prevalence radiological required sclerosis Seizures Seven stroke Tertiary the SARS-CoV-2 the WHO Treatment response
[DOI] 10.3389/fneur.2021.640017 PMC 바로가기 [Article Type] Neurology

Case Report: Concomitant Massive Cerebral Venous Thrombosis and Internal Iliac Vein Thrombosis Related to Paucisymptomatic COVID-19 Infection

Neurology

Published on 2021-02-102022-11-01
Journal: Frontiers in Neurology [Category] COVID-19,

[키워드] Active surveillance Admission Affect anticoagulation Asymptomatic cerebral Cerebral venous thrombosis Clinical course Complication Concomitant COVID-19 COVID-19 infection COVID-19 patients CT scan Fever Galen headache Hypoxemia Infection internal internal iliac vein thrombosis interstitial pneumonia late phase low molecular weight malignancy massive neurologic neurological deficits outcome Patient Pelvic repeated respiratory symptoms SARS-CoV-2 SARS-COV-2 infection serological test silent subarachnoid hemorrhage Support Swab tested Thromboinflammation thrombosis thrombotic complication treated Treatment unfractionated heparin Vein venous Venous thrombosis with COVID-19
[DOI] 10.3389/fneur.2021.622130 PMC 바로가기 [Article Type] Neurology

Blood Biomarkers for Detection of Brain Injury in COVID-19 Patients

COVID-19 환자의 뇌 손상 감지를 위한 혈액 바이오마커

Review

Published on 2021-01-012022-09-10
Journal: Journal of Neurotrauma [Category] MERS, 바이오마커, 유전자 메커니즘, 진단,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Affect analyzed approved Biomarker Blood blood biomarkers Brain Cardiac arrest cerebrospinal fluid Clinical practice CNS CNS injury coronavirus coronavirus disease Coronavirus disease 2019 Course COVID-19 COVID-19 patients CSF description detect detection diagnose Diagnosis diagnostic Diseases drug Drug administration Efficacy Elevation elevations ENhance epilepsy food GFAP, SARS-CoV-2 highlight hospitalized COVID-19 patient hospitalized COVID-19 patients Human immunodeficiency virus hypoxia immunodeficiency virus improvement Improvements Infection Infectious diseases Injury management mechanism Meningitis Mild moderate multiple organ multiple organs mutability nervous system neurological Neurological deficit neurological deficits outcome Pathways Patient Patient management patients predict Protein rationale reported Research respiratory SARS-CoV-2 SARS-CoV-2 virus severe acute respiratory syndrome Coronavirus severity stroke Symptom the disease therapeutic intervention therapeutic interventions Traumatic brain injury treat Triage tuberculous tuberculous meningitis U.S. Food and Drug Administration UCH-L1 urgency Viral virus virus attack virus attacks
[DOI] 10.1089/neu.2020.7332 PMC 바로가기 [Article Type] Review

Perspectives for the use of therapeutic Botulinum toxin as a multifaceted candidate drug to attenuate COVID-19

Review article

Published on 2020-06-012022-10-05
Journal: Medicine in Drug Discovery [Category] 신약개발,

[키워드] ACE2 acute respiratory syndrome appear attenuate Botox Botulinum toxin Brain circulation clinical symptom Clinical symptoms coronavirus coronavirus disease Coronavirus-2 cough country COVID-19 death dose Dyspnoea functional global public health humans individuals with COVID-19 induce Infection life-threatening lung Lungs Mild multi-organ dysfunction neurodegeneration Neurological deficit neurological deficits other organ outbreak paralysis Pneumonia Prevent provide pulmonary failure purified Respiratory failure resulting SARS-CoV-2 SARS-COV-2 infection the SARS-CoV-2 therapeutic therapeutic use virus while
[DOI] 10.1016/j.medidd.2020.100042 [Article Type] Review article

Acute Respiratory Failure Secondary to COVID-19 Viral Pneumonia Managed With Hydroxychloroquine/Azithromycin Treatment

Anesthesiology

Published on 2020-05-252022-10-31
Journal: Cureus [Category] COVID-19,

Zebrafish slc30a10 deficiency revealed a novel compensatory mechanism of Atp2c1 in maintaining manganese homeostasis

Zebrafish slc30a10 결핍은 망간 항상성을 유지하는 Atp2c1의 새로운 보상 메커니즘을 밝혀냈습니다

Research Article

Published on 2017-07-102022-09-06
Journal: PLoS Genetics [Category] Communicable Disease,

[키워드] absence accompanied accumulated activating adulthood approach ATP2C1 ATPase Author Brain can be used characterized cirrhosis cirrhosis) clinically CRISPR deficiency degenerative degenerative diseases develop disease Disease model disorder dysregulation dystonia early-onset EDTA effective Embryo embryonic ENCODE expressing expression fibrosis form HeLa cells hepatic injury homeostasis Impaired impaired function implicated inhibit iron liver Liver fibrosis manganese manganism mechanism metabolic disorder metabolism modulating mutant mutant embryo mutant embryos mutants Mutation neurological Neurological deficit neurological deficits neurological impairment pharmacological phenotype physiological polycythemia recent reduce rescued secretory pathway Signaling significantly higher SLC30A10 specific treatment steatosis therapy underlie wild-type zebrafish
[DOI] 10.1371/journal.pgen.1006892 PMC 바로가기 [Article Type] Research Article